Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002050709-25-000009
Filing Date
2025-10-24
Accepted
2025-10-24 16:37:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11239
2 Squadron_ex1.pdf EX-1 48947
  Complete submission text file 0002050709-25-000009.txt   80438
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Subject) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91004 | Film No.: 251416622
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address P.O. BOX 462 HINSDALE IL 60522
Business Address P.O. BOX 462 HINSDALE IL 60522 8474819500
Squadron Capital Management LLC (Filed by) CIK: 0002050709 (see all company filings)

EIN.: 884254921 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G